ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,975, issued on June 9, was assigned to WECARE PROBIOTICS Co. LTD. (Jiangsu, China). "Lactobacillus plantarum against Helicobacter pylori inf... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,977, issued on June 9, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "Generation of neurons by reprog... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,978, issued on June 9, was assigned to University of Massachusetts (Westborough, Mass.). "Methods and compositions for treating GM1 ganglios... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,979, issued on June 9, was assigned to Nutramax Laboratories Inc. (Lancaster, S.C.). "Compositions comprising sulforaphane or a sulforaphane... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,980, issued on June 9, was assigned to COSMAX INC. (Gyeonggi-Do, South Korea). "Composition for preventing or ameliorating bromhidrosis comp... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,981, issued on June 9, was assigned to KING SAUD UNIVERSITY (Riyadh, Saudi Arabia). "Acacia nilotica based hydrogel and method of making the... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,982, issued on June 9, was assigned to CMOL PHARMACEUTICALS AUSTRALIA PTY LTD (North Willoughby, Australia). "Herbal medicine composition an... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,983, issued on June 9, was assigned to U.S. NUTRACEUTICALS INC. (Eustis, Fla.). "Composition and method having enhanced LSESr to maintain an... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,984, issued on June 9, was assigned to LEGACY HEALTHCARE (SWITZERLAND) SA (Epalinges, Switzerland). "Long term treatment of psoriasis" was i... Read More
ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,985, issued on June 9, was assigned to Hexamer Therapeutics Inc. (Pullman, Wash.). "Immunotherapeutic for prostate cancer treatment" was inv... Read More